Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5526_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
29 Мб
Скачать
384
C. I. Deligianni and T. Mavridis

40.6 Treatment

The treatment of headache in pheochromocytoma is focused on controlling the underlying cause—excess catecholamine secretion—and managing the associated hypertension. Several therapeutic strategies are employed:
1. Antihypertensive therapy: α-blockers, such as phenoxybenzamine, are used to
control hypertension and prevent the vasoconstrictive effects of excessive cate­cholamines. These medications also help alleviate headaches by reducing blood pressure uctuations.
2. Heart rate: β-blockers (e.g., propranolol) can be added to control tachycardia and
reduce the adrenergic stimulation that contributes to the headache. Nevertheless, β-blockers should never be started before α-blockers, as unopposed alpha­adrenergic stimulation may worsen the hypertensive crisis.
3. Surgical resection: The denitive treatment for pheochromocytoma is surgical
resection of the tumor, which leads to normalization of catecholamine levels and, therefore, most patients experience resolution of symptoms, including headaches.
4. Management of hypertensive crises: Intravenous medications such as nitroprus-
side or labetalol may be used to control acute blood pressure elevations, which can also lead to headache relief if present.

40.7 Conclusion

Headache is a common but often overlooked symptom in patients with pheochro­mocytoma, and it is essential to consider this diagnosis in patients presenting with unexplained headache, primarily when associated with other systemic symptoms such as hypertension, palpitations, and sweating. Clinical suspicion leads to early diagnosis and treatment, which are crucial for preventing complications and improv­ing outcomes. Physicians must be vigilant when evaluating prolonged headaches in the emergency setting. Medical management, including alpha and beta blockade, followed by surgical resection of the tumor, remains the cornerstone of treatment. Prompt recognition and appropriate intervention can provide signicant relief from the debilitating symptoms associated with this rare but signicant condition.

References

1. Anyfanti P, Mastrogiannis Κ, Lazaridis Α, Tasios Κ, Vasilakou D, Kyriazidou Α, Aroutsidis F, Pavlidou O, Papoutsopoulou Ε, Tiritidou A, Kotsis V, Triantafyllou Α, Zaris Ι, Douma S, Gkaliagkousi Ε. Clinical presentation and diagnostic evaluation of pheochromocytoma: case series and literature review. Clin Exp Hypertens. 2023;45(1):2132012. https://doi.org/10.108
0/10641963.2022.2132012.
40 Headache Attributed toPheochromocytoma
2. Farrugia FA, Martikos G, Tzanetis P, Charalampopoulos A, Misiakos E, Zavras N, Sotiropoulos D. Pheochromocytoma, diagnosis and treatment: review of the literature. Endocr Regul. 2017;51(3):168–81.
3. Gupta PK, Marwaha B. Pheochromocytoma. [Updated 2024 Nov 7]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.
nih.gov/books/NBK589700/.
4. Ghanizada H, Al-Karagholi MA, Arngrim N, Mørch-Rasmussen M, Walker CS, Hay DL, Ashina M. Effect of adrenomedullin on migraine-like attacks in patients with migraine: a randomized crossover study. Neurology. 2021;96(20):e2488–99. https://doi.org/10.1212/
WNL.0000000000011930. Epub 2021 Apr 7. PMID: 33827963.
5. D'Andrea G, D'Arrigo A, Dalle Carbonare M, Leon A. Pathogenesis of migraine: role of neuromodulators. Headache. 2012;52(7):1155–63. https://doi.org/10.1111/
j.1526- 4610.2012.02168.x. Epub 2012 Jun 1. PMID: 22671857.
6. Leonard JB, Munir KM, Kim HK.Metoclopramide induced pheochromocytoma crisis. Am J Emerg Med. 2018;36(6):1124.e1–2.
7. Neumann HPH, Young WF Jr, Eng C.Pheochromocytoma and Paraganglioma. N Engl J Med. 2019;381(6):552–65.
8. The International Classication of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1–211. Jes Olesen ISSN: 0333-1024.
9. Do TP, Remmers A, Schytz HW, Schankin C, Nelson SE, Obermann M, Hansen JM, Sinclair AJ, Gantenbein AR, Schoonman GG. Red and orange ags for secondary headaches in clinical practice: SNNOOP10 list. Neurology. 2019;92(3):134–44. https://doi.org/10.1212/
WNL.0000000000006697.
10. Bravo EL, Gifford RW Jr. Pheochromocytoma. Endocrinol Metab Clin N Am. 1993;22(2):329–41.
11. Manger WM, Gifford RW. Pheochromocytoma. J Clin Hypertens (Greenwich). 2002;4(1):62–72.
12. Bravo EL.Pheochromocytoma: new concepts and future trends. Kidney Int. 1991;40(3):544–56.
13. Nehs MA, Ruan DT.Minimally invasive adrenal surgery: an update. Curr Opin Endocrinol Diabetes Obes. 2011;18(3):193–7.
14. Ando Y, Ono Y, Sano A, Fujita N, Ono S, Tanaka Y.Clinical characteristics and outcomes of pheochromocytoma crisis: a literature review of 200 cases. J Endocrinol Investig. 2022;45(12):2313–28. PMID: 35857218.
15. Schwedt TJ. Thunderclap Headache. Continuum (Minneap Minn). 2015;21(4 Headache):1058–71. https://doi.org/10.1212/CON.0000000000000201. PMID: 26252591.
16. Patel D, Phay JE, Yen TWF, Dickson PV, Wang TS, Garcia R, Yang AD, Solórzano CC, Kim LT.Update on pheochromocytoma and paraganglioma from the SSO endocrine/head and neck disease-site work group. Part 1 of 2: advances in pathogenesis and diagnosis of pheochromo­cytoma and paraganglioma. Ann Surg Oncol. 2020;27(5):1329–37. https://doi.org/10.1245/
s10434- 020- 08220- 3. Epub 2020 Feb 28. PMID: 32112212; PMCID: PMC8655649.
17. Taïeb D, Timmers HJ, Hindié E, Guillet BA, Neumann HP, Walz MK, Opocher G, de Herder WW, Boedeker CC, de Krijger RR, Chiti A, Al-Nahhas A, Pacak K, Rubello D, European Association of Nuclear Medicine. EANM 2012 guidelines for radionuclide imaging of pha­eochromocytoma and paraganglioma. Eur J Nucl Med Mol Imaging. 2012;39(12):1977–95.
https://doi.org/10.1007/s00259- 012- 2215- 8. Epub 2012 Aug 28. PMID: 22926712; PMCID:
PMC4714772.
https://doi.org/10.1515/enr- 2017- 0018.
https://doi.org/10.1007/s40618- 022- 01868- 6. Epub 2022 Jul 20.
385
Chapter 41
Headache Attributed toHypertensive Encephalopathy
MarioFernandoPrietoPeres

41.1 Introduction

Headaches are one of the most common symptoms seen in emergency departments. However, when associated with an acute rise in blood pressure and neurological changes, it can signal a life-threatening condition called hypertensive encephalopa­thy. This syndrome is characterised by a breakdown in cerebral autoregulation lead­ing to vasogenic oedema and, if not recognised promptly, can lead to seizures, coma or death [1, 2].
Within the spectrum of hypertensive crises, hypertensive encephalopathy stands out because of its complex clinical-radiological overlap with other neurological emergencies. It can present with acute or subacute onset of headache, visual distur­bances, altered mental status and even focal neurological decits—features that often mimic stroke, pre-eclampsia/eclampsia or cerebral venous thrombosis [3, 4]. The most recognised radiological correlate is posterior reversible encephalopathy syndrome (PRES), which is associated with reversible vasogenic oedema, predomi­nantly in the parieto-occipital lobes [57]. However, PRES represents only one aspect of the spectrum of hypertensive encephalopathy and should not be consid­ered synonymous with it [8, 9].
Clinical diagnosis is further challenged by the broad differential diagnosis, par­ticularly in special populations such as pregnant women, where the distinction between hypertensive encephalopathy, eclampsia and migraine with aura may be blurred [10, 11]. In addition, unusual imaging patterns—including brainstem,
M. F. P. Peres (*) Elect International Headache Society, Institute of Psychiatry, University of Sao Paulo, Sao Paulo, Brazil
Hospital Israelita Albert Einstein, Sao Paulo, Brazil
Switzerland AG 2026 D. Uludüz et al. (eds.), Rare Causes of Headache Disorders, Headache,
https://doi.org/10.1007/978-3-032-10242-3_41
387© The Author(s), under exclusive license to Springer Nature
388
M. F. P. Peres
cerebellar, spinal cord and frontal lobe involvement—may be seen in hypertensive encephalopathy, which may delay diagnosis [1214].
Emerging evidence also suggests that reversible cerebral vasoconstriction syn­drome (RCVS) may coexist with or mimic hypertensive encephalopathy, especially when it presents with thunderclap headache and dynamic vascular changes on mag­netic resonance (MR) angiography [1517].
This chapter focuses on headaches attributed to hypertensive encephalopathy, illustrated through a representative clinical case involving a third-trimester pregnant woman with hypertensive crisis and radiological features of PRES.Beyond the clas­sical narrative, we will explore atypical imaging patterns, potential overlaps with RCVS and diagnostic dilemmas in differential diagnosis, particularly in pregnancy­related hypertensive states. We will also provide practical clinical guidance on neu­roimaging, ophthalmological signs and management strategies to prevent irreversible neurological damage.
41.2 Pathophysiology (Fig.41.1)
Hypertensive encephalopathy is a neurologic emergency that lies on the spectrum of hypertensive crises. Its pathophysiology is primarily attributed to the failure of cere­bral autoregulation under acute, severe blood pressure elevations. This leads to a
Fig. 41.1 Pathophysiological mechanism of headache in hypertensive encephalopathy. (This g- ure was created on the Biorender)
41 Headache Attributed toHypertensive Encephalopathy
389
hyperperfusion state, endothelial dysfunction and leakage of plasma and proteins into the interstitial space, resulting in vasogenic oedema, most prominent in poste­rior brain regions due to their relatively sparse sympathetic innervation [5, 7]. While posterior reversible encephalopathy syndrome (PRES) is the most widely recog­nised neuroimaging pattern of this process, not all hypertensive encephalopathy cases meet the PRES criteria. Conversely, not all cases of PRES are of hypertensive origin [6, 8].

41.3 Case Presentation

Zeynep, a 42-year-old woman in her 32nd week of pregnancy with her third child, presented to the emergency department with a sudden and intensely distressing headache that had started approximately 2 hours prior. She described the onset as abrupt and explosive, ‘as if something burst inside my head’, with immediate full intensity. The pain was primarily located at the occipital region, radiating upward and forward toward the vertex and bilateral temples. She noted that it throbbed and pulsed with each heartbeat, but with periods where it felt like a tightening band pressing against her skull.
She rated the headache intensity as 9 out of 10, unresponsive to rest or the paracetamol she had taken at home. Unlike previous mild, tension-type headaches during her earlier pregnancies, this episode was profoundly different in both quality and severity. Associated symptoms included nausea, phonophobia and dizziness, particularly when changing positions. She also reported neck stiffness and a feeling of restlessness, frequently shifting in bed and unable to nd relief. She denied fever, trauma or preceding aura symptoms. While visual blurring and ashing lights were present, she was more troubled by a heavy, internal head pressure and a sense of ‘mental fog’ that made it difcult to concentrate or respond promptly to questions.
She had no prior history of hypertension or migraines but had missed several prenatal follow-ups. Her two previous pregnancies were uncomplicated.
On examination, she was hypertensive with a blood pressure of 210/120mmHg and mildly confused. Neurologically, she had brisk deep tendon reexes and bilat­eral ankle clonus. An ophthalmological bedside exam revealed mild bilateral papill­edema. Visual acuity was decreased but correctable, and she had difculty with visual eld testing. The fundoscopic examination showed blurred disc margins and venous engorgement, with mild ame-shaped haemorrhages suggestive of grade II hypertensive retinopathy.
A comprehensive neuroimaging workup was performed. MRI Brain (T2-FLAIR­diffusion) The MRI ndings in this case are highly consistent with posterior revers­ible encephalopathy syndrome (PRES) secondary to hypertensive encephalopathy. On T2-weighted and uid-attenuated inversion recovery (FLAIR) sequences, there are bilateral, symmetrical hyperintense signal changes predominantly involving the parieto-occipital lobes, affecting both the cortical and subcortical white matter. These regions demonstrate no mass effect or enhancement, and the pattern is typical
390
M. F. P. Peres
for vasogenic oedema. Additionally, subtle hyperintensities in the cerebellar hemi­spheres—particularly on the right—further support a posterior circulation vulnera­bility. Diffusion-weighted imaging (DWI) shows mild hyperintensities without corresponding low signal on apparent diffusion coefcient (ADC) maps; instead, the ADC values are elevated, indicating facilitated diffusion and conrming the presence of vasogenic rather than cytotoxic oedema. The absence of true diffusion restriction effectively rules out acute infarction. These ndings reect the patho­physiology of PRES, in which severe hypertension overwhelms the cerebral auto­regulatory mechanisms, especially in posterior circulation territories with relatively less sympathetic innervation, leading to transient blood–brain barrier disruption and uid extravasation into the interstitium. Collectively, the imaging demonstrates the classic radiologic pattern of PRES, supporting a diagnosis of reversible vasogenic oedema due to hypertensive encephalopathy. Given the clinical and radiological ndings, Zeynep was diagnosed with hypertensive encephalopathy in the context of severe preeclampsia, with radiological features of PRES.
Treatment was initiated with intravenous labetalol to stabilise her blood pressure and magnesium sulphate for seizure prophylaxis. Obstetrics was consulted immedi­ately. After maternal stabilisation, she was transferred to the high-risk maternal care unit. Delivery planning was initiated in close collaboration with the perinatol­ogy team.
Over the next 72hours, the intensity of her headache gradually lessened, and her visual symptoms began to resolve. Serial ophthalmological assessments showed improving disc clarity and resolution of venous dilation. A follow-up MRI 1 month later revealed partial regression of the T2-FLAIR abnormalities.

41.4 Clinical Presentation

Headache is often the earliest and most prominent symptom in hypertensive enceph­alopathy. It may precede more overt signs, such as altered mental status, visual disturbances or seizures, as a crucial diagnostic clue [1, 10]. The headache is typi­cally bilateral, throbbing and in the occipital region, though variations exist. The presence of a new-onset severe headache, particularly in a patient with markedly elevated blood pressure and neurological complaints, should prompt urgent investi­gation for hypertensive encephalopathy [16].
The headache phenomenology in hypertensive encephalopathy may mimic or overlap with other secondary headache causes, especially in pregnant or peripartum individuals. This emphasises the need for structured symptom evaluation and a high index of suspicion in emergency and primary care settings.
41 Headache Attributed toHypertensive Encephalopathy
391

41.5 Differential Diagnosis

• Preeclampsia/Eclampsia: Both share overlapping features with hypertensive
encephalopathy, including elevated blood pressure, headache and visual distur-
bances. However, systemic ndings such as proteinuria, elevated liver enzymes
and thrombocytopenia help differentiate them [3].
• Reversible Cerebral Vasoconstriction Syndrome (RCVS): It is characterised by
thunderclap headaches and reversible narrowing of cerebral arteries. MRA is
critical in identifying dynamic segmental vasoconstriction [15].
• Cerebral Venous Sinus Thrombosis (CVST): It can present with subacute head-
ache and visual symptoms, sometimes with preserved consciousness. MRV is
essential for differentiation.
• Hypertensive Intracerebral Haemorrhage: It often presents with sudden, focal
decits and altered consciousness. Non-contrast computed tomography (CT) is
the rst-line investigation in suspected cases.
• Pituitary Apoplexy and Posterior Fossa Mass Lesions: Although less common,
these should be considered in cases of headaches with visual loss, particularly in
pregnant women.
• Primary Headaches Exacerbated by Blood Pressure Elevation: Migraine, tension-
type and cluster headaches can all trigger transient increases in blood pressure,
but in these cases, the hypertension is usually secondary, not causal.
However, the diagnostic process is complicated by the broad differential diagno­sis of headaches in hypertensive and pregnant patients. In pregnant individuals like the case presented, differentials include preeclampsia/eclampsia, cerebral venous sinus thrombosis (CVST), reversible cerebral vasoconstriction syndrome (RCVS), pituitary apoplexy and even migraine with aura. Each may present with similar neurological signs and symptoms, including headache, visual changes and altered consciousness [3, 11].
Differentiating hypertensive encephalopathy from eclampsia is particularly criti­cal in obstetric patients. Both conditions may involve elevated blood pressure, sei­zures and cerebral oedema, yet eclampsia often includes additional systemic features such as proteinuria, hepatic dysfunction and thrombocytopenia. Neuroimaging in both conditions may show PRES patterns, further complicating the diagnosis. Nonetheless, the presence of isolated neurological symptoms with a radiologic PRES pattern, in the absence of systemic signs, leans toward primary hypertensive encephalopathy [4].
Similarly, RCVS is a signicant diagnostic consideration. Thunderclap headache is the hallmark of RCVS, and MRA often reveals segmental vasoconstriction in cerebral arteries, a nding that may also be observed in hypertensive encephalopa­thy [15]. Both syndromes may coexist or mimic each other, especially in postpar­tum or peripartum patients. The key distinction lies in the dynamic reversibility of vascular narrowing in RCVS and the dominant oedema patterns in PRES-like hypertensive encephalopathy [5, 6].
392
Imaging plays a pivotal role in diagnosis. MRI is superior to CT in detecting the hallmark vasogenic oedema of hypertensive encephalopathy. Typical ndings include bilateral, symmetrical hyperintensities in the parieto-occipital white matter on T2- and FLAIR-weighted sequences. However, less typical presentations involve the frontal lobes, cerebellum, brainstem and spinal cord. Imaging abnormalities may persist long after symptom resolution, especially in chronic or undertreated conditions [14].
Ophthalmological examination is another essential, often underutilised, diagnos­tic tool. Papilledema and hypertensive retinopathy provide real-time evidence of elevated intracranial pressure and systemic vascular injury. In the case of hyperten­sive encephalopathy, ndings such as blurred disc margins, venous engorgement, ame haemorrhages or cotton wool spots reinforce the urgency of neurological evaluation [2, 4].
M. F. P. Peres

41.6 Conclusion

In summary, headache is not merely a symptom in hypertensive encephalopathy—it is a diagnostic cornerstone. Its characteristics, evolution and associated ndings guide the clinician toward or away from competing diagnoses. It is key to timely diagnosis and management to understand its role, alongside careful systemic evalu­ation, neuroimaging and fundoscopic examination. Failure to act on these early clues can lead to irreversible cerebral injury, seizures or death [13, 17].

41.7 Key Messages

• Headache can be the earliest and most critical clue in diagnosing hypertensive
encephalopathy. New-onset severe headache in the presence of acute hyperten-
sion should prompt urgent neurological evaluation.
• Hypertensive encephalopathy is pathophysiologically distinct from but radio-
logically overlapping with posterior reversible encephalopathy syndrome
(PRES). Not all PRES is hypertensive in origin, and not all cases of hypertensive
encephalopathy manifest as classical PRES.
• In pregnant patients, hypertensive encephalopathy should be differentiated from
preeclampsia/eclampsia, cerebral venous sinus thrombosis, RCVS and migraine
with aura. Systemic ndings and dynamic neuroimaging features aid in differen-
tial diagnosis.
• MRI with advanced sequences (T2-FLAIR, DWI, MRA, MRV) is essential for
identifying vasogenic oedema, ruling out infarction or haemorrhage and evaluat-
ing vascular changes suggestive of RCVS or CVST.
41 Headache Attributed toHypertensive Encephalopathy
393
• Ophthalmological examination, including fundoscopy, is a valuable bedside tool.
Papilledema and hypertensive retinopathy ndings can guide urgency and indi-
cate elevated intracranial pressure.
• Prompt treatment, including blood pressure control and seizure prophylaxis, can
lead to complete recovery and radiological reversal in most cases, especially
when diagnosed early.

References

1. Potter T, Agarwal A, Schaefer TJ.Hypertensive encephalopathy. 2024 Feb 2. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 32119386.
2. Tsou TP, Yen ZS, Fang CC, Chen SC, Chen WJ.Hypertensive encephalopathy. J Emerg Med. 2004;27(1):85–6. https://doi.org/10.1016/j.jemermed.2004.02.014. PMID: 15219310.
3. Astarita A, Covella M, Vallelonga F, Cesareo M, Totaro S, Ventre L, Aprà F, Veglio F, Milan A. Hypertensive emergencies and urgencies in emergency departments: a system­atic review and meta-analysis. J Hypertens. 2020;38(7):1203–10. https://doi.org/10.1097/
HJH.0000000000002372. PMID: 32510905.
4. Christopoulou F, Rizos EC, Kosta P, Argyropoulou MI, Elisaf M.Does this patient have hyper­tensive encephalopathy? J Am Soc Hypertens. 2016;10(5):399–403. https://doi.org/10.1016/j.
jash.2016.01.020. Epub 2016 Jan 29. PMID: 26896240.
5. Triplett JD, Kutlubaev MA, Kermode AG, Hardy T. Posterior reversible encephalopathy syndrome (PRES): diagnosis and management. Pract Neurol. 2022;22(3):183–9. https://doi.
org/10.1136/practneurol- 2021- 003194. Epub 2022 Jan 19. PMID: 35046115.
6. Ando Y, Ono Y, Sano A, Fujita N, Ono S. Posterior reversible encephalopathy syn­drome: a review of the literature. Intern Med. 2022;61(2):135–41. https://doi.org/10.2169/
internalmedicine.7520- 21. Epub 2021 Jul 17. PMID: 34275982; PMCID: PMC8851194.
7. Fugate JE, Rabinstein AA. Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol. 2015;14(9):914–25. 2015 Jul 13. Erratum in: Lancet Neurol. 2015 Sep;14(9):874. https://doi.org/10.1016/ S1474-4422(15)00195-7. PMID: 26184985.
8. Mirza A.Posterior reversible encephalopathy syndrome: a variant of hypertensive encephalop­athy. J Clin Neurosci. 2006;13(5):590–5. https://doi.org/10.1016/j.jocn.2005.03.042. PMID:
16769518.
9. Schwartz RB, Jones KM, Kalina P, Bajakian RL, Mantello MT, Garada B, Holman BL.Hypertensive encephalopathy: ndings on CT, MR imaging, and SPECT imaging in 14 cases. AJR Am J Roentgenol. 1992;159(2):379–83. https://doi.org/10.2214/ajr.159.2.1632361. PMID: 1632361.
10. Tang-Wai DF, Phan TG, Wijdicks EF.Hypertensive encephalopathy presenting with thunder­clap headache. Headache. 2001;41(2):198–200.
111006198.x. PMID: 11251706.
11. Minville V, N'Guyen L, Coustet B, Fourcade O, Samii K. Hypertensive encephalopathy mimicking postdural puncture headache in a parturient beyond the edge of reproductive age. Anesth Analg. 2004;99(6):1873–4. https://doi.org/10.1213/01.ANE.0000137806.09323.36. PMID: 155620.
12. Nagato M, Takahashi Y, Yoshioka M, Nambu M.A case of hypertensive encephalopathy with extensive spinal lesions on MRI.Brain Dev. 2010;32(7):598–601. https://doi.org/10.1016/j.
braindev.2009.07.002. Epub 2009 Sep 5. PMID: 19733990.
https://doi.org/10.1016/S1474- 4422(15)00111- 8. Epub
https://doi.org/10.1046/j.1526- 4610.2001.
394
13. Ille O, Woimant F, Pruna A, Corabianu O, Idatte JM, Haguenau M.Hypertensive enceph­alopathy after bilateral carotid endarterectomy. Stroke. 1995;26(3):488–91. https://doi.
org/10.1161/01.str.26.3.488. PMID: 7886730.
14. Ito S, Ito T, Tamura N, Uchiyama T, Mori M, Hattori T.Chronic hypertensive encepha­lopathy showing only headache: report of a case with long-standing brain MR abnor­malities suggesting extensive vasogenic edema. Eur Neurol. 2005;53(4):220–2. https://doi.
org/10.1159/000086736. Epub 2005 Apr 4. PMID: 16015008.
15. Perillo T, Paolella C, Perrotta G, Serino A, Caranci F, Manto A.Reversible cerebral vaso­constriction syndrome: review of neuroimaging ndings. Radiol Med. 2022;127(9):981–90.
https://doi.org/10.1007/s11547- 022- 01532- 2. Epub 2022 Aug 6. PMID: 35932443; PMCID:
PMC9362037.
16. Spierings EL.Acute and chronic hypertensive headache and hypertensive encephalopathy. Cephalalgia. 2002;22(4):313–6.
12100095.
17. Grönbaek E. Acute and chronic hypertensive headache and hypertensive encepha­lopathy. Cephalalgia. 2003;23(3):238–9; author reply 239. https://doi.org/10.1046/
j.1468- 2982.2003.04851.x. PMID: 12662195.
https://doi.org/10.1046/j.1468- 2982.2002.00333.x. PMID:
M. F. P. Peres